Company / Interest Expense per Share
Olema Pharmaceuticals, Inc. Interest Expense per Share History
FY2020-FY2020 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$0.09
FY2020
5-year range
$0.09 / $0.09
FY2020-FY2020
Trend
-
vs FY2019
Sector context
#26 of 43
Health Care
What the data says
At $0.09, Olema Pharmaceuticals, Inc.'s interest expense per share ranks #18 of 43 in the Health Care sector.
Based on SEC 10-K filings.
0.09 in FY2020.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#18 of 43 in Health CareTop 40% of 43This company $0.09 Sector average $18.61
▼
-99.5% below sector average
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.74 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | - | - |
| FY2023 | - | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | $0.09 | - |
| FY2019 | - | - |
As of FY2020 · SEC 10-K · Updated Feb 28, 2026